Issue #35 · May 13
Happy Wednesday! Samsung's AI-powered wearable breakthrough, record-setting drug approvals, and a billion-dollar biotech deal are leading the week 👀
This week’s highlights feature key developments in Korea’s biotech industry,
along with updates on upcoming KoreaBIO-hosted events.

Don’t miss the lastest news—read till the end!
THIS WEEK: 
WHAT WE'VE BEEN UP TO
Video Updates
In March, KoreaBIO visited BIO-Europe Spring 2026!
We're excited to share Part 1 of our journey—the Pre-event Day highlights.
KoreaBIO MEMBER NEWS

Oscotec Launches Platform Technology Team for Anti-Resistance Cancer Therapy Platform.

NexThera Reports Positive Phase 1/2a Safety and Vision Data for Wet AMD Eyedrop NT-101.

ACROBiosystems to Host Webinar on Key Target Proteins Involved in Autoimmune Diseases.

ACROBiosystems to Host Webinar on Addressing Challenges in ADC Development.

Crescom Showcases AI-Based Knee Joint Analysis Technology on MBN’s Healthcare Program “Body Insight.”

IVIM Technology Expands Global Outreach Through Seminars and Workshops in the U.S. and Europe.

Sartorius Korea Research Center Obtains EU GMP Certification.

GCCL Supports Clinical Trial Analysis for Curocell’s CAR-T Therapy Rimqarto Approval.

Dt&CRO Appoints Vice President Kim Bong-tae to Strengthen Biotech Ventures and Drug Development Support.

Neurophet to Accelerate U.S. Expansion After Unveiling “Neurophet AQUA AD Plus” at ASNR 2026.

ProBio Demonstrates Integrated CDMO Capabilities for Curocell CAR-T Therapy Rimqarto Approval.

Dt&CRO Wins Grand Prize at 2nd Korea AI Innovation Grand Awards with Clinical Trial Platform.

WHAT'S COMING UP?
Here's what's happening across Korea's bio industry!
WHAT'S HAPPENING
KOREA GOES GLOBAL
INNOVATION & TRENDS
GROWTH & PERFORMANCE

Learn More? [Visit our Website]

New here? Join 2,700+ insatiably curious readers [Sign up here]

Missed Something? Check up on [Past Issues]

Korea Biotechnology Industry Organization (KoreaBIO)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea